| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Hospital & Healthcare Services
|
Compare with Industry peers |
| Website | http://www.metropolisindia.com | |
| Market Cap | 9,300.59 Cr. | |
| Enterprise Value(EV) | 9,153.40 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 24.35 | Trailing Twelve Months Ending 2023-12 |
| Price-Earning Ratio (PE) | 74.55 | Trailing Twelve Months Ending 2023-12 |
| Industry PE | 66.96 | Trailing Twelve Months Ending 2023-12 |
| Book Value / Share | 209.61 | Trailing Twelve Months Ending 2023-12 |
| Price to Book Value | 8.66 | Calculated using Price: 1,815.50 |
| Dividend Yield | 0.44 | Period Ending 2023-03 |
| No. of Shares Subscribed | 5.12 Cr. | 51,228,806 Shares |
| FaceValue | 2 | |
| About Metropolis Healthcare Ltd. | ||
| Metropolis Healthcare is engaged in the business of providing pathology and related healthcare services. The profile comprises of a variety of test combinations which are specific to a disease or disorder as well as wellness profiles that are used for health and fitness screening. It classifies its tests into ‘routine' tests such as blood chemistry analyses, blood cell counts and urine examination; ‘semi-specialized' tests such as thyroid function tests, viral and bacterial cultures, histology, cytology and infectious disease tests; and ‘specialized' tests such as tests for coagulation studies, autoimmunity tests, cytogenetics and molecular diagnostics. It is focused on providing reliable test results as well as value-added services such as home collection of specimens and online access to test reports. It also offers customized wellness packages to its institutional customers as per their requirement. | ||
| 1 Day |
|
+1.95% |
| 1 Week |
|
+2.20% |
| 1 Month |
|
+6.12% |
| 3 Month |
|
+15.63% |
| 6 Month |
|
+32.12% |
| 1 Year |
|
+46.14% |
| 2 Year |
|
-23.72% |
| 5 Year |
|
+92.77% |
| 10 Year |
|
| 9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | 18.77 | 26.16 | 36.47 | 30.38 | 29.82 | 27.21 | 30.07 | 27.31 | 15.46 | |
| Return on Capital Employed (%) | 27.47 | 40.06 | 54.28 | 45.22 | 44.77 | 37.79 | 41.6 | 34.39 | 19.83 | |
| Return on Assets (%) | 14.48 | 19.06 | 23.75 | 16.93 | 15.33 | 14.72 | 18.43 | 15.31 | 8.3 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 361 | 265 | 323 | 415 | 419 | 524 | 707 | 886 | 988 | 1,047 | |
| Non Curr. Liab. | 10 | 1 | 16 | 148 | 142 | 195 | 111 | 493 | 417 | 202 | |
| Curr. Liab. | 75 | 105 | 152 | 233 | 241 | 210 | 240 | 364 | 303 | 250 | |
| Minority Int. | 23 | 20 | 21 | 14 | 1 | 2 | 1 | 2 | 2 | 3 | |
| Equity & Liab. | 468 | 391 | 512 | 810 | 803 | 930 | 1,059 | 1,745 | 1,710 | 1,502 | |
| Non Curr. Assets | 167 | 166 | 227 | 367 | 381 | 492 | 415 | 1,289 | 1,370 | 1,199 | |
| Curr. Assets | 302 | 225 | 285 | 443 | 422 | 438 | 645 | 455 | 341 | 303 | |
| Misc. Exp. not W/O | |||||||||||
| Total Assets | 468 | 391 | 512 | 810 | 803 | 930 | 1,059 | 1,745 | 1,710 | 1,502 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
| Net Sales | 455 | 524 | 545 | 647 | 761 | 856 | 998 | 1,228 | 1,148 | 1,159 | |
| Other Income | 6 | 22 | 26 | 8 | 8 | 9 | 12 | 20 | 17 | 8 | |
| Total Income | 461 | 546 | 570 | 655 | 769 | 865 | 1,010 | 1,248 | 1,166 | 1,167 | |
| Total Expenditure | -337 | -388 | -391 | -469 | -557 | -619 | -708 | -883 | -857 | -886 | |
| PBIDT | 124 | 158 | 179 | 186 | 212 | 246 | 302 | 366 | 309 | 281 | |
| Interest | -2 | -2 | -2 | -4 | -4 | -13 | -12 | -25 | -32 | -23 | |
| Depreciation | -21 | -21 | -17 | -19 | -20 | -39 | -46 | -63 | -89 | -91 | |
| Taxation | -33 | -46 | -53 | -52 | -63 | -41 | -61 | -79 | -44 | -41 | |
| Exceptional Items | -8 | -25 | 16 | ||||||||
| PAT | 68 | 82 | 107 | 112 | 124 | 128 | 183 | 215 | 143 | 125 | |
| Minority Interest | -7 | -8 | -8 | -3 | 0 | 0 | -1 | -1 | -1 | ||
| Share Associate | -6 | ||||||||||
| Other Related Items | |||||||||||
| Consolidated Net Profit | 61 | 74 | 102 | 104 | 120 | 127 | 183 | 214 | 143 | 125 | |
| Adjusted EPS | 12 | 15 | 20 | 21 | 24 | 25 | 36 | 42 | 28 | 24 |
| Particulars | 7 years | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | 102 | 104 | 90 | 215 | 249 | 253 | 247 | |
| Cash Fr. Inv. | -86 | 2 | 35 | -105 | 62 | -738 | 47 | |
| Cash Fr. Finan. | -17 | -87 | -118 | -55 | -33 | 163 | -292 | |
| Net Change | -1 | 19 | 7 | 55 | 278 | -322 | 2 | |
| Cash & Cash Eqvt | 26 | 43 | 51 | 107 | 387 | 66 | 69 |
|
Thu, 18 Apr 2024
Updates Metropolis Healthcare Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 (Listing Regulations)'. |
|
Thu, 18 Apr 2024
Sale or disposal-XBRL Metropolis Healthcare Limited has informed the Exchange regarding Sale or disposal of unit(s)/division(s)/subsidiary |
|
Sat, 13 Apr 2024
Certificate under SEBI (Depositories and Participants) Regulations, 2018 Metropolis Healthcare Limited has informed the Exchange about Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 |
| Mon, 29 Apr 2024 |
Close Within 52 Week High Zone
|
High Increase in 3 Months
|
High Increase in 6 Months
|
High Increase in 1 Year
|
William %R Trending Down
|
